Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Cells
|
July 27, 2022
Transcriptional Regulation of the Hippo Pathway: Current Understanding and Insights from Single-Cell Technologies
Sayantanee Paul, Shiqi Xie, Xiaosai Yao, et al.
Trends in Cancer
|
July 26, 2017
Epigenomic Consequences of Coding and Noncoding Driver Mutations
Xiaosai Yao, Manjie Xing, Wen Fong Ooi, et al.
International Journal of Cancer
|
September 22, 2010
CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response
Dung T Le, Brian H Ladle, Timothy Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 31, 2014
Tumor cells are dislodged into the pulmonary vein during lobectomy
Xiaosai Yao, Christina Williamson, Viktor A Adalsteinsson, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
September 3, 2013
Single cells from human primary colorectal tumors exhibit polyfunctional heterogeneity in secretions of ELR+ CXC chemokines
Viktor A Adalsteinsson, Narmin Tahirova, Naren Tallapragada, et al.
International Journal of Cancer
|
June 19, 2013
Determination of 35 cell surface antigen levels in malignant pleural effusions identifies CD24 as a marker of disseminated tumor cells
Xiaosai Yao, Myriam Labelle, Carla R Lamb, et al.
Nature Cancer
|
January 13, 2025
ERα dysfunction caused by ESR1 mutations and therapeutic pressure promotes lineage plasticity in ER<sup>+</sup> breast cancer
Jackson Liang, Xiaosai Yao, Patrick Aouad, et al.
Cancer Research
|
March 5, 2026
The Hippo Pathway is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1 Resistant Cancer
Juliette Roels, Hamid Ghaedi, Jayaram Kancherla, et al.
Cell Chemical Biology
|
May 20, 2026
Giredestrant immobilizes the estrogen receptor to exert potent antitumor efficacy against ER-active breast cancers
Wei Zhou, Musaddeque Ahmed, Jane Guan, et al.
Science Translational Medicine
|
September 21, 2022
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer
Jackson Liang, Ellen Rei Ingalla, Xiaosai Yao, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Cells
|
July 27, 2022
Transcriptional Regulation of the Hippo Pathway: Current Understanding and Insights from Single-Cell Technologies
Sayantanee Paul, Shiqi Xie, Xiaosai Yao, et al.
Trends in Cancer
|
July 26, 2017
Epigenomic Consequences of Coding and Noncoding Driver Mutations
Xiaosai Yao, Manjie Xing, Wen Fong Ooi, et al.
International Journal of Cancer
|
September 22, 2010
CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response
Dung T Le, Brian H Ladle, Timothy Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 31, 2014
Tumor cells are dislodged into the pulmonary vein during lobectomy
Xiaosai Yao, Christina Williamson, Viktor A Adalsteinsson, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
September 3, 2013
Single cells from human primary colorectal tumors exhibit polyfunctional heterogeneity in secretions of ELR+ CXC chemokines
Viktor A Adalsteinsson, Narmin Tahirova, Naren Tallapragada, et al.
International Journal of Cancer
|
June 19, 2013
Determination of 35 cell surface antigen levels in malignant pleural effusions identifies CD24 as a marker of disseminated tumor cells
Xiaosai Yao, Myriam Labelle, Carla R Lamb, et al.
Nature Cancer
|
January 13, 2025
ERα dysfunction caused by ESR1 mutations and therapeutic pressure promotes lineage plasticity in ER<sup>+</sup> breast cancer
Jackson Liang, Xiaosai Yao, Patrick Aouad, et al.
Cancer Research
|
March 5, 2026
The Hippo Pathway is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1 Resistant Cancer
Juliette Roels, Hamid Ghaedi, Jayaram Kancherla, et al.
Cell Chemical Biology
|
May 20, 2026
Giredestrant immobilizes the estrogen receptor to exert potent antitumor efficacy against ER-active breast cancers
Wei Zhou, Musaddeque Ahmed, Jane Guan, et al.
Science Translational Medicine
|
September 21, 2022
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer
Jackson Liang, Ellen Rei Ingalla, Xiaosai Yao, et al.
Page
of 4